Alamar Biosciences, Inc Common Stock

Alamar Biosciences, Inc Common Stock

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$33,545
$29,427
$26,035
$25,045
Gross Profit
20,644
17,718
14,457
14,838
EBITDA
-13,095
-11,934
-19,471
-5,615
EBIT
-13,095
-13,068
-20,638
-6,689
Net Income
-13,342
-13,199
-21,325
-7,136
Net Change In Cash
33,545
29,427
26,035
25,045
Free Cash Flow
-15,195
-14,964
-20,947
-17,475
Cash
121,532
132,969
64,586
30,002
Basic Shares
69,106
58,665
69,311
67,916

Annual Financials

Values in thousands2025-12-312024-12-31
Revenue
$74,211
$25,142
Gross Profit
41,705
8,607
EBITDA
-24,889
-41,788
EBIT
-28,753
-44,982
Net Income
-29,819
-47,073
Net Change In Cash
74,211
25,142
Free Cash Flow
-59,992
-58,602
Cash
30,002
26,770
Basic Shares
66,521
66,521

Earnings Calls

QuarterEPS
2026-09-30
-$0.19
2026-06-30
-$0.22
2026-03-31
-$1.74